Table 3 Clinical and laboratory characteristics of the group of patients (12 patients) where LEF-1 was remeasured at day 28
Case (N) | Age (years) | Sex | Cytogenetic | Hb (g/dl) | TLC × 109/L | Plt × 109/L | PB blast % | BM blast % | LEF-1 (log10) | Follow-up LEF-1 (log10) | Fate | Response (D 28) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 32 | F | t(15;17) | 9.1 | 5.8 | 114 | 12 | 70 | 13.93 | 3.21 | Alive | HR |
2 | 30 | F | t(8,21) | 10.9 | 9.6 | 111 | 30 | 80 | 15.51 | 2.11 | Alive | HR |
3 | 50 | F | t(8,21) | 9.1 | 12.3 | 80 | 16 | 88 | 11.51 | 1.74 | Alive | HR |
4 | 32 | M | t(8,21) | 8.6 | 10 | 80 | 24 | 56 | 11.39 | 1.36 | Alive | HR |
5 | 47 | M | Normal | 9 | 6 | 90 | 15 | 80 | 12.13 | 12.28 | Died | IR |
6 | 28 | F | Normal | 13.1 | 3.7 | 77 | 8 | 85 | 13.07 | 13.31 | Died | IR |
7 | 36 | M | Normal | 8.6 | 12 | 88 | 9 | 99 | 10.11 | 9.95 | Died | IR |
8 | 53 | F | t(15,17) | 9 | 4 | 156 | 30 | 95 | 15.39 | 2.51 | Alive | HR |
9 | 30 | M | t(15,17) | 10 | 4 | 80 | 35 | 30 | 13.52 | 1.82 | Alive | HR |
10 | 37 | M | t(15,17) | 11 | 5 | 90 | 40 | 60 | 11.53 | 1.93 | Alive | HR |
11 | 64 | M | 11q23 | 6.4 | 83.7 | 28 | 90 | 91 | 0.7 | 0.5 | Died | IR |
12 | 68 | M | 11q23 | 6.6 | 70.8 | 16 | 40 | 67 | 1.78 | 1.62 | Died | IR |